The GNL3L ‐ MDM2 Interaction Drives Esophageal Squamous Cell Carcinoma Progression
Cancer Medicine · 2025
DOI: 10.1002/cam4.71146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Aijie Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Qilu Hospital of Shandong University (Qingdao), Qingdao, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-mdm2, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This study investigates the mechanisms by which GNL3L influences ESCC progression.
Methods
GNL3L expression was analyzed via immunohistochemistry in ESCC tissues. Cell proliferation (EdU and CCK8 assays), migration, invasion (wound healing and Transwell assays), cell cycle, and apoptosis (flow cytometry) were assessed. Levels of GNL3L, MDM2, p53, and p21 were evaluated by qRT‐PCR and western blot. Tumor growth was observed in nude mice injected with TE‐1 cells.
Results
GNL3L was upregulated in ESCC specimens ( p < 0.05) and knockdown reduced proliferation and migration while enhancing apoptosis ( p < 0.01). GNL3L interacted with MDM2; knocking down GNL3L decreased MDM2 and increased p53 and p21 ( p < 0.01). MDM2 overexpression enhanced malignant characteristics, reversible by GNL3L silencing ( p < 0.01). Moreover, MDM2 knockdown inhibited malignant characteristics, reversible by GNL3L overexpression ( p < 0.01). In vivo, the sh‐GNL3L group exhibited the smallest tumor volumes after 5 weeks ( p < 0.01).
Conclusions
GNL3L correlates with ESCC malignancy, influencing the MDM2‐p53‐p21 axis. GNL3L‐MDM2 interaction is critical in ESCC progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiotherapy, Qilu Hospital of Shandong University (Qingdao), Qingdao, China.
- Department of Pathology, Qilu Hospital of Shandong University (Qingdao), Qingdao, China.
- Department of Radiation Oncology, Qilu Hospital of Shandong University, Jinan, China.
ORCID-Profile: Yufeng Cheng
Zitieren
APA
Yang, A., Song, H., & Cheng, Y. (2025). The GNL3L ‐ MDM2 Interaction Drives Esophageal Squamous Cell Carcinoma Progression. Cancer Medicine. https://doi.org/10.1002/cam4.71146
Vancouver
Yang A, Song H, Cheng Y. The GNL3L ‐ MDM2 Interaction Drives Esophageal Squamous Cell Carcinoma Progression. Cancer Medicine. 2025. doi:10.1002/cam4.71146
BibTeX
@article{Yang2025,
author = {Yang, Aijie and Song, Haiyun and Cheng, Yufeng},
title = {The GNL3L ‐ MDM2 Interaction Drives Esophageal Squamous Cell Carcinoma Progression},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.71146}
}
EUVIMED